hiv-mag
Vaccineexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2011 (NCT01496989)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hiv-mag
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01859325 | Phase 1 | May 10, 2013 | National Institute of Allergy and Infectious Diseases (NIAID), Profectus BioSciences, Inc. |
| NCT01578889 | Phase 1 | May 1, 2012 | National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
| NCT01496989 | Phase 1 | Dec 1, 2011 | Ichor Medical Systems Incorporated, International AIDS Vaccine Initiative, Profectus BioSciences, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 2012 |
| Profectus BioSciences, Inc. | For profit | 2 | 0 | 1 | 2011 |
| Ichor Medical Systems Incorporated | For profit | 1 | 0 | 1 | 2011 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 1 | 1 | 2011 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2012 |
5 organizations
Page 1 / 1